SCHEMBL20179602

SCHEMBL20179602

Nc1ccc2c(c1)OCCN2CCNCCCN1CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 4/20 0.39
NOS1 P29475 4/20 0.39
HTR1A P08908 1/20 0.35
SLC6A4 P31645 1/20 0.35
NOS2 P35228 3/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
LCK P06239 1/20 0.34
TNK2 Q07912 1/20 0.34
KDM1A O60341 3/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SIGMAR1 Q99720 2/20 0.33
NPY5R Q15761 3/20 0.33
CYP2C19 P33261 2/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17525497 0.89 NOS3 (0.42) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525496 0.88 NOS3 (0.43) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525495 0.87 NOS1 (0.41) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525489 0.86 NOS3 (0.43) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525478 0.86 NOS3 (0.43) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525491 0.85 KDM1A (0.45) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17859565 0.85 NOS3 (0.40) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525488 0.84 NOS3 (0.44) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17525490 0.83 KDM1A (0.43) NOS3NOS1NOS2CYP2D6KDM1A
SCHEMBL17525487 0.82 NOS3 (0.46) NOS3NOS1HTR1ASLC6A4NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141922-A1 BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING L'OREAL (FR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141922-A1 BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING XDH, KRT18, CYC1 NOS3 602/4885NOS1 1127/4885HTR1A 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.